Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR

Mycoses

Volumn 57, Issue 2, 2014, Pages 69-78

  Fraczek, Marcin G ^a,b   Kirwan, Marie B ^a,b   Moore, Caroline B ^a,b   Morris, Julie ^b   Denning, David W ^a,b   Richardson, Malcolm D ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Aspergillus; Bronchoalveolar lavage; Culture; QPCR; Sputum

Indexed keywords

ADULT; AGED; ARTICLE; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BODILY SECRETIONS; BRONCHIAL ASPIRATION PROCEDURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE TECHNIQUE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FUNGUS CULTURE; FUNGUS GROWTH; FUNGUS ISOLATION; HUMAN; HUMAN TISSUE; LUNG ASPERGILLOSIS; LUNG LAVAGE; MIDDLE AGED; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT SECRETION; SENSITIVITY ANALYSIS; SPUTUM ANALYSIS;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; FUNGI;

ASPERGILLUS; BRONCHOALVEOLAR LAVAGE; CULTURE; QPCR; SPUTUM;

ASPERGILLOSIS; ASPERGILLUS; BODILY SECRETIONS; BRONCHOALVEOLAR LAVAGE FLUID; GREAT BRITAIN; HUMANS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING;

EID: 84892875745     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12103     Document Type: Article

References (22)

1. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-50.
2. Bouza E, Guinea J, Peláez T, Pérez-Molina J, Alcalá L, Muñoz P. Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol 2005; 43: 2075-9.
3. Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 2005; 5: 609-22.
4. Buckley M. The fungal kingdom: diverse and essential roles in earth's ecosystem. A report from the American College of Microbiology. 2008; 1-48. URL http://academy.asm.org/images/stories/documents/fungalkingdom.pdf.
5. Denning DW, Hope WW. Therapy for fungal diseases: opportunities and priorities. Trends Microbiol 2010; 18: 195-204.
6. von Eiff M, Roos N, Schulten R, Hesse M, Zühlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62: 341-7.
7. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47: 503-9.
8. Greene RE, Schlamm HT, Oestmann JW et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis 2007; 44: 373-9.
9. Arendrup MC, Chryssanthou E, Gaustad P, Koskela M, Sandven P, Fernandez V. Diagnostics of fungal infections in the Nordic countries: we still need to improve!. Scand J Infect Dis 2007; 39: 337-43.
10. Health Protection Agency (HPA). BSOP57; investigation of bronchoalveolar lavage, sputum and associated specimens. National Standard Method 2009; 2.3: 1-27.
11. Health Protection Agency (HPA). BSOP57; investigation of bronchoalveolar lavage, sputum and associated specimens. UK Standards Microbiol Investig 2012; 2.4: 1-29.
12. Bakare N, Rickerts V, Bargon J, Just-Nübling G. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003; 46: 19-23.
13. Pashley CH, Fairs A, Morley JP et al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol 2012; 50: 433-8.
14. MycAssay Aspergillus product insert. 2010 Feb 17; Version 2.2.
15. Subcommittee on Antifungal Susceptibility Testing of the ESCMID. European Committee for Antimicrobial Susceptibility Testing EUCAST technical note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin Microbiol Infect 2008; 14: 982-4.
16. Health Protection Agency (HPA). QSOP52, inoculation of culture media. National Standard Method 2008; 1: 1-13.
17. Baxter CG, Jones AM, Webb K, Denning DW. Homogenisation of cystic fibrosis sputum by sonication-an essential step for Aspergillus PCR. J Microbiol Methods 2011; 85: 75-81.
18. Denning DW, Park S, Lass-Florl C et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011; 52: 1123-9.
19. Lass-Flörl C, Salzer GM, Schmid T, Rabl W, Ulmer H, Dierichi MP. Pulmonary Aspergillus colonization in humans and its impact on management of critically ill patients. Br J Haematol 1999; 104: 745-7.
20. Bafadhel M, McKenna S, Agbetile J et al. Aspergillus fumigatus during stable state and exacerbations of COPD. Eur Respir J 2013 [Epub ahead of print].
21. Borman AM, Palmer MD, Delhaes L et al. Lack of standardization in the procedures for mycological examination of sputum samples from CF patients: a possible cause for variations in the prevalence of filamentous fungi. Med Mycol 2010; 48(Suppl. 1): S88-97.
22. Duddy N, Moore C, Kent P, Richardson M, Denning D, Reutemaa-Richardson R. QPCR is significantly more sensitive in detecting Aspergillus in respiratory samples than culture. 5th Advances Against Aspergillosis. Istanbul, Turkey, 26-28 January 2012; 57; 125.